Transactions

Achelous Partners has selected the following announced M&A transactions and advisory work to illustrate our client commitment and our expertise in a variety of life science and healthcare fields.
January 2023
has been acquired by
The undersigned acted as financial advisor to ECIR Medical Communications Inc.
January 2023
has been acquired by
The undersigned acted as financial advisor to Alcedis, GmbH
November 2022
has been acquired by
The undersigned acted as financial advisor to Expression Systems, LLC
October 2022
has been acquired by
The undersigned acted as financial advisor to AQW Holdings, Inc. d.b.a. Qfix
August 2022
has been acquired by
The undersigned acted as financial advisor to AusDiagnostics
July 2022
has been acquired by
The undersigned acted as financial advisor to Cergentis B.V.
July 2022
has been acquired by
The undersigned acted as financial advisor to proderm GmbH
June 2022
has been acquired by
The undersigned acted as financial advisor to SAI MedPartners
February 2022
has acquired
The undersigned acted as financial advisor to TCP Analytical
November 2021
has been acquired by
The undersigned acted as financial advisor to Regulatory Compliance Associates Inc.
August 2021
has been acquired by
The undersigned acted as financial advisor to DRG International Inc.
August 2021
has been acquired by
The undersigned acted as financial advisor to bioskin GmbH
July 2021
has been acquired by
The undersigned acted as financial advisor to nanoComposix Holdings, Inc.
May 2021
has been acquired by
The undersigned acted as financial advisor to Clinical Outcomes Solutions
March 2021
has been acquired by
The undersigned acted as financial advisor to Diamond Pharma Services
February 2021
has been acquired by
The undersigned acted as financial advisor to Delphi Genetics
October 2020
has been acquired by
The undersigned acted as financial advisor to MD Biosciences, Inc.
September 2020
has been acquired by
The undersigned acted as financial advisor to American Laboratory Products Company, Ltd.
September 2020
has been acquired by
The undersigned acted as financial advisor to Maetrics LLC
August 2020
has been acquired by
The undersigned acted as financial advisor to CTK Biotech, Inc.
February 2020
has been acquired by
The undersigned acted as financial advisor to BresMed Health Solutions Ltd
January 2020
has been acquired by
The undersigned acted as financial advisor to Statistics Collaborative, Inc.
December 2019
has been acquired by
The undersigned acted as financial advisor to MLM Medical Labs GmbH
October 2019
has been acquired by
The undersigned acted as financial advisor to Specialized Medical Services-oncology BV
July 2019
has been acquired by
The undersigned acted as financial advisor to Eurolyser Diagnostica GmbH
July 2019
has acquired
The undersigned acted as financial advisor to LifeSpan BioSciences
March 2019
has been acquired by
The undersigned acted as financial advisor to Quorum Review, Inc.
January 2019
has been acquired by
The undersigned acted as financial advisor to ProductLife Group
January 2019
has been acquired by
The undersigned acted as financial advisor to CoreBiome, Inc.
October 2018
has been acquired by
The undersigned acted as financial advisor to Pennside Partners Ltd.
September 2018
has been acquired by
The undersigned acted as financial advisor to NovaTec Immundiagnostica GmbH
September 2018
has acquired
The undersigned acted as financial advisor to Thompson Street Capital Partners
September 2018
has been acquired by
The undersigned served as financial advisor to HyTest Ltd.
July 2018
has been acquired by
The undersigned served as financial advisor to Gold Standard Diagnostics Corp.
May 2018
has been acquired by
The undersigned served as financial advisor to Biovian Oy
January 2018
has been acquired by
The undersigned served as financial advisor to LifeCodexx AG
June 2017
has been acquired by
The undersigned acted as financial advisor to Coté Orphan, LLC
May 2017
has been acquired by
The undersigned acted as financial advisor to PharmaCell B.V.
April 2017
has been acquired by
The undersigned acted as financial advisor to Emergo Group, Inc.
April 2017
has been acquired by
The undersigned acted as financial advisor to Calbiotech, Inc.
January 2017
has been acquired by
The undersigned acted as financial advisor to BioControl Systems, Inc.
August 2016
has been acquired by
The undersigned acted as financial advisor to SPEware Corporation
July 2016
has acquired
The undersigned acted as financial advisor to Sharps Compliance Corp.
June 2016
has been acquired by
The undersigned acted as financial advisor to Cisbio Bioassays
December 2015
has acquired
The undersigned acted as financial advisor to Abzena plc
December 2015
has acquired
The undersigned acted as financial adviser to Sharps Compliance Corp.
October 2015
has been acquired by
The undersigned acted as financial advisor to Kinesis Pharma BV
August 2015
has been acquired by
The undersigned acted as financial advisor to DIAsource ImmunoAssays SA
July 2015
has acquired
The undersigned acted as financial advisor to Sharps Compliance Corp.
March 2015
has acquired
The undersigned acted as financial advisor to Ansell Limited
July 2014
has been acquired by
The undersigned acted as financial advisor to IBL International Holding BV
July 2014
has been acquired by
The undersigned served as financial advisor to Phlexglobal Limited
June 2014
has acquired
The undersigned acted as financial advisor to Spectris plc
June 2014
has been acquired by
The undersigned served as financial advisors to Pharmalink Consulting
December 2013
has acquired assets from
The undersigned acted as advisor to Valeant Pharmaceuticals International
August 2013
has been acquired by
The undersigned acted as financial advisor to Kirkegaard & Perry Laboratories Inc
July 2013
has been acquired by
The undersigned acted as financial advisor to The Anson Group LLC
July 2013
has signed a definitive agreement to sell its orthopedic implant assets and business to
an Apax Partners company The undersigned acted as financial advisor to Austofix Group Limited
July 2013
has been acquired by
The undersigned acted as financial advisor to Kreatech Holding B.V.
July 2013
has been acquired by
USD$10,000,000
The undersigned acted as financial advisor to Matrical Bioscience Inc
May 2013
has been acquired by
The undersigned acted as advisor to Triangle Biomedical Sciences Inc.
August 2012
has been acquired by
The undersigned acted as advisor to JSW Life Sciences GmbH
March 2012
has acquired assets from
US$164M plus up to US$20M in milestones
The undersigned acted as advisor to Valeant Pharmaceuticals International
December 2011
invests in
The undersigned acted as advisor to Ansell Limited for the investment
August 2010
has been acquired by
The undersigned acted as financial advisor to EnviroLogix, Inc.
March 2010
has been acquired by
USD$59,000,000
The undersigned acted as financial advisor to Finnzymes Oy
December 2009
has licensed its ReGet® drug delivery system for ophthalmic indications to
The undersigned acted as financial advisor to BTG olc
October 2009
has been acquired by
The undersigned acted as financial advisor to Anaspec Inc.
August 2009
has sold its HySolv™ drug delivery technology to
The undersigned acted as financial advisor to BTG plc
January 2009
has been acquired by
The undersigned acted as financial advisor to the shareholders of Labcoat Limited
December 2008
has acquired
The undersigned is acting as financial advisor to Biocompatibles International
December 2008
has acquired
The undersigned rendered a Fairness Opinion to Affymetrix, Inc.
February 2008
has been acquired by
The undersigned is acting as financial advisor to Sigma Pharmaceuticals
January 2008
has been acquired by
The undersigned is acting as financial advisor to Panbio Limited
May 2007
has acquired
The undersigned acted as financial advisor to Ansell Limited
March 2007
has sold its Human Health point-of-care diagnostic products business to
The undersigned acted as financial advisor to Agenix Limited
February 2007
Strategic alliance and investment of up to £32,100,000 in
The undersigned acted as financial advisor to GeneMedix, PLC
December 2006
Announced M&A advisory and restructuring
The undersigned acted as financial advisor to Panbio Limited
December 2006
has acquired
The undersigned acted financial advisor to Novozymes A/S
August 2006
has acquired
The undersigned acted as financial advisor to Meditech Research Limited
July 2006
has acquired Delta Biotechnology Ltd from
The undersigned acted as financial advisor to Novozymes A/S
April 2006
has assigned IP and granted distribution rights for its Animal Health business to
The undersigned acted as financial advisor to Agenix Limited
October 2005
M&A advisory and valuation analysis
The undersigned acted as financial advisor to CogState Limited
September 2005
NASDAQ listing of ADRs (American Depositary Receipts)
The undersigned acted as advisor to Genetic Technologies Limited
June 2005
NASDAQ listing of ADRs (American Depositary Receipts)
The undersigned acted as advisor to ChemGenex Pharmarceuticals Limited
January 2005
awarded to
for its investment banking role in the creation of
December 2004
has been acquired by
The undersigned acted as financial advisor to AGT Biosciences Ltd.
© 2023 Achelous Partners. 800 Third Avenue, 21st Floor, New York, NY 10022   /   Tel: 212.660.7250   /   Fax: 917.475.9457   /   Privacy Policy   /   site by cleverdesign